Clinical Trial

Analysis of TPE Treatments With multiFiltratePRO

Study acronym: TPEopt
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 28, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Analysis of therapeutic plasma exchange (TPE) treatments to assess the performance of the TPE mode of multiFiltratePRO based on the successful exchange of plasma from whole blood. The multiFiltratePRO is a device for extracorporeal blood purification treatments.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-02-21; most recent amendment 2025-08-27.
Status change: Not Yet Recruiting → Recruiting 2024-09-18
Trial Details
NCT Number NCT06272084
Lead Sponsor Fresenius Medical Care Deutschland GmbH
Collaborators: X-act Cologne Clinical Research GmbH
Conditions Autoimmune Diseases
Enrollment 60 participants
Start Date 2024-05-22
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-28